A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments proved "life changing". While most patients have 20 days of radiotherapy over ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

Alpha Tau Medical Ltd (DRTS) announced an update on their ongoing clinical study. Study Overview – Alpha Tau Medical Ltd. (NASDAQ: DRTS) is launching a new safety study titled “A Safety Study of ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...

SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...